Background: Intraductal papillary cholangiocarcinoma is a preinvasive type of biliary tract cancer with a relatively favorable prognosis, requiring complete resection of the involved bile ducts and corresponding liver segments (Christodoulou et al. in J Gastrointest Surg, 2024; Sucandy et al. in Collab Study Ann Surg Oncol 31:81-89, 2024; Magistri et al. in Eur J Surg Oncol 49:107002, 2023; Sucandy et al. in Ann Surg Oncol 30:8559-8560, 2023). When located in the perihilar region, mild cholangitis and segmental or lobular biliary obstruction are often the presenting findings. Herein, we demonstrate our technique for robotic resection of intraductal cholangiocarcinoma with biliary reconstruction and portal lymphadenectomy.
Patients And Methods: A 78-year-old woman presented with recurrent fever and left hepatic duct filling defects with ipsilateral biliary dilation, concerning for intraductal cholangiocarcinoma. Computed tomography (CT) and magnetic resonance imaging (MRI) indicated a lesion within the left hepatic duct involving biliary bifurcation. After the portal lymphadenectomy, the distal common bile duct was transected with scissors. A choledochoscope was inserted into the proximal extrahepatic duct to visualize the tumor location and extent. After obtaining inflow control, the anatomical left hepatectomy was undertaken with caudate resection. An ultrasonic dissector was used for parenchymal transection. Once the specimen was removed, a retrocolic Roux-en-Y-hepaticojejunostomy was fashioned to the right anterior, right posterior, and accessory right dorsal hepatic duct as a single anastomosis following unification ductoplasty technique. We did not feel the need to place biliary stents owing to the relatively large composite size of the bile ducts after ductoplasty (more than 1 cm in total). The caudate lobe biliary branch was about 6-7 mm in size, which is an acceptable diameter in our practice to perform a robotic anastomosis without placing a biliary ductal stent.
Results: The operation was completed uneventfully with 50 ml of blood loss. After an uncomplicated recovery, she was discharged home on postoperative day six. She is currently two years post-resection without recurrent disease.
Discussion: The level of proximal bile duct transection is determined by a combination of detailed preoperative radiological evaluation (using MRI/MRCP/CT scan) and intraoperative clinical investigation using choledoschope/Spyglass biliary endoscope. The lumen of the bile duct is endoscopically visualized using Spyglass to determine proximal end of tumor involvement. Once this is endoscopically visualized, robotic camera is then directed and focused to search transilluminating light originated from the end of the Spyglass. Gentle external tapping on the proximal bile duct wall using robotic scissors is applied to confirm the transection level while observing the endoscopic view at all time. After each transection of the bile duct, cut ends (bile duct stumps/margins) were evaluated and confirmed to be negative through intraoperative frozen section pathological examination, as the oncological primary goals.
Conclusions: Robotic resection of intraductal cholangiocarcinoma with biliary reconstruction and portal lymphadenectomy is safe and feasible with excellent outcomes. We believe this approach will become an alternative to the conventional open operation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1245/s10434-025-17027-z | DOI Listing |
J Surg Case Rep
March 2025
Department of Gastrointestinal Surgery, Birat Medical College and Teaching Hospital (BMCTH), Tankisinwari, Morang, Biratnagar 56613, Nepal.
Lemmel's syndrome is a rare condition characterized by obstructive jaundice due to the periampullary duodenal diverticulum in the absence of choledocholithiasis or tumors. Its infrequent occurrence and non-specific clinical presentation can make it difficult to distinguish from other conditions. We present a case of Lemmel's syndrome in a 63-year-old male who exhibited symptoms of abdominal pain in right hypochondrium, vomiting, and fever.
View Article and Find Full Text PDFCureus
February 2025
Surgery, Hospital Regional General Ignacio Zaragoza, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, MEX.
Introduction Laparoscopic cholecystectomy (LC) is a standard surgical procedure that general surgeons perform to treat acute cholecystitis. The presentation of this condition can vary in severity due to preoperative and intraoperative risk factors. Intraoperative scales such as the Parkland Grading Scale (PGS), Nassar Scale (NS), and G10 Score (G10S) evaluate these aspects.
View Article and Find Full Text PDFFront Oncol
February 2025
Department of Cancer Drug Discovery and Development, Research Center, Osaka International Cancer Institute, Osaka, Japan.
Background: and preclinical examinations of cancer cell lines are performed to determine the effectiveness of new drugs before initiating clinical trials. However, there is often a significant disparity between the promising results observed in preclinical evaluations and actual outcomes in clinical trials. Therefore, we hypothesized that this inconsistency might be due to the differences between the characteristics of cell lines and actual cancers in patients.
View Article and Find Full Text PDFWorld J Surg
March 2025
Division of GI Surgery, GI Oncology, Minimal Access and Bariatric Surgery, Institute of Digestive and Hepatobiliary Sciences, Medanta - The Medicity, Gurugram, India.
Introduction: High-biliary injuries are associated with worse outcomes. Most series do not mention failure rates specific to the injury grade. In our experience, Strasberg E4 injuries are associated with a higher failure rate.
View Article and Find Full Text PDFInt J Mol Sci
February 2025
Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Gastrointestinal (GI) cancers, which mainly include malignancies of the esophagus, stomach, intestine, pancreas, liver, gallbladder, and bile duct, pose a significant global health burden. Unfortunately, the prognosis for most GI cancers remains poor, particularly in advanced stages. Current treatment options, including targeted and immunotherapies, are less effective compared to those for other cancer types, highlighting an urgent need for novel molecular targets.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!